Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Ibrahim, Bassem (57202669921)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
    (2021)
    Sliwa, Karen (57207223988)
    ;
    van der Meer, Peter (7004669395)
    ;
    Petrie, Mark C. (7006426382)
    ;
    Frogoudaki, Alexandra (6508286015)
    ;
    Johnson, Mark R. (7406603972)
    ;
    Hilfiker-Kleiner, Denise (6602676885)
    ;
    Hamdan, Righab (14827968900)
    ;
    Jackson, Alice M. (57031159500)
    ;
    Ibrahim, Bassem (57202669921)
    ;
    Mbakwem, Amam (6506969430)
    ;
    Tschöpe, Carsten (7003819329)
    ;
    Regitz-Zagrosek, Vera (7006921582)
    ;
    Omerovic, Elmir (6603106682)
    ;
    Roos-Hesselink, Jolien (6701744808)
    ;
    Gatzoulis, Michael (7005950602)
    ;
    Tutarel, Oktay (6603479050)
    ;
    Price, Susanna (7202475463)
    ;
    Heymans, Stephane (6603326423)
    ;
    Coats, Andrew J.S. (35395386900)
    ;
    Müller, Christian (59579510000)
    ;
    Chioncel, Ovidiu (12769077100)
    ;
    Thum, Thomas (57195743477)
    ;
    de Boer, Rudolf A. (8572907800)
    ;
    Jankowska, Ewa (21640520500)
    ;
    Ponikowski, Piotr (7005331011)
    ;
    Lyon, Alexander R. (57203046227)
    ;
    Rosano, Giuseppe (7007131876)
    ;
    Seferovic, Petar M. (6603594879)
    ;
    Bauersachs, Johann (7004626054)
    This position paper focusses on the pathophysiology, diagnosis and management of women diagnosed with a cardiomyopathy, or at risk of heart failure (HF), who are planning to conceive or present with (de novo or previously unknown) HF during or after pregnancy. This includes the heterogeneous group of heart muscle diseases such as hypertrophic, dilated, arrhythmogenic right ventricular and non-classified cardiomyopathies, left ventricular non-compaction, peripartum cardiomyopathy, Takotsubo syndrome, adult congenital heart disease with HF, and patients with right HF. Also, patients with a history of chemo-/radiotherapy for cancer or haematological malignancies need specific pre-, during and post-pregnancy assessment and counselling. We summarize the current knowledge about pathophysiological mechanisms, including gene mutations, clinical presentation, diagnosis, and medical and device management, as well as risk stratification. Women with a known diagnosis of a cardiomyopathy will often require continuation of drug therapy, which has the potential to exert negative effects on the foetus. This position paper assists in balancing benefits and detrimental effects. © 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback